Nektar Therapeutics
NKTR
NKTR
229 hedge funds and large institutions have $561M invested in Nektar Therapeutics in 2022 Q3 according to their latest regulatory filings, with 30 funds opening new positions, 70 increasing their positions, 73 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
4% less repeat investments, than reductions
Existing positions increased: 70 | Existing positions reduced: 73
19% less capital invested
Capital invested by funds: $692M → $561M (-$131M)
Holders
229
Holding in Top 10
–
Calls
$2M
Puts
$219K
Top Buyers
| 1 | +$11.1M | |
| 2 | +$8.19M | |
| 3 | +$3.12M | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$2.59M |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$2.33M |
Top Sellers
| 1 | -$29.8M | |
| 2 | -$12.2M | |
| 3 | -$8.65M | |
| 4 |
AllianceBernstein
Nashville,
Tennessee
|
-$3.49M |
| 5 |
State Street
Boston,
Massachusetts
|
-$2.79M |